If you, your children, or your grandchildren have asthma, you know how important an inhaler can be.
On April 4, 2017, GlaxoSmithKline (GSK) announced that they were voluntarily recalling almost 600,000 Ventolin inhalers.
According to the Asthma and Allergy Foundation of America, GSK is recalling the inhalers due to faulty packaging.
The company received some complaints that the inhalers were leaking while in the pouches, which means the inhalers could provide fewer doses than shown on the dose counter.
According to the FDA, the voluntary Class II recall means that “use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
What this means in plain English is that there are no serious adverse health effects — the only thing people need to be concerned about is running out of doses sooner than expected.
[H/T: Good Housekeeping]